KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study

Summary

The main purpse of this study is to evaluate the safety and tolerability of KSD-101 in patients with advanced clear cell renal cell carcinoma, to evaluate the initial clinical outcomes , immune response, and to evaluate the impact of KSD-201 on the quality of life in patients with advanced clear cell renal cell carcinoma.

Timeline

Start

2026-03-01

Primary completion

2026-03-17

Completion

2026-03-17

Outcome

Outcome not reported

Stopped (Business): “Due to a strategic adjustment, the company has decided to terminate the project.”

Drugs

Indications